Javascript must be enabled to continue!
Molecular Mechanisms Associated with Chromosomal and Microsatellite Instability in Sporadic Glioblastoma multiforme
View through CrossRef
<i>Objective:</i> Two chromosomal instability (CIN) pathways are described in glioblastoma multiforme (GBM), type 1 and type 2, which can be observed in up to 70% of the cases. Microsatellite instability (MSI) plays a pathogenic role in sporadic cancers such as colon, gastric and endometrial carcinomas with deficient mismatch repair (MMR). We aimed to perform a comprehensive analysis of the relationship between CIN and MSI mechanisms in sporadic glioblastomas. <i>Methods:</i> 129 GBMs were examined (109 newly diagnosed and 20 relapses) investigating MSI, immunohistochemical expression of MMR proteins as well as sequencing and promoter methylation of <i>hMLH1</i>. We characterized the molecular changes frequently correlated with CIN in MSI+ GBMs and compared them with 26 microsatellite-stable tumors. <i>Results:</i> Low-level MSI was observed in 11 of 129 (8.5%) cases and was higher in relapses than in primary GBMs (25 vs. 5.5%, p = 0.027). High-level MSI was not found in any case. A deficient expression of MLH1 and PMS2 without <i>hMLH1</i> inactivation was observed only in one giant cell GBM. 55% of the MSI+ GBMs showed a profile which did not correspond to one of the known CIN pathways. An inverse association was observed between MSI and mutations of both <i>p53 </i>and <i>PTEN</i>. <i>Conclusions:</i> Our data suggest that CIN and MSI contribute to the genomic instability in GBMs via independent pathways. Since MSI was significantly more frequent in relapses, it might play a role in the malignant progression of GBM.
Title: Molecular Mechanisms Associated with Chromosomal and Microsatellite Instability in Sporadic Glioblastoma multiforme
Description:
<i>Objective:</i> Two chromosomal instability (CIN) pathways are described in glioblastoma multiforme (GBM), type 1 and type 2, which can be observed in up to 70% of the cases.
Microsatellite instability (MSI) plays a pathogenic role in sporadic cancers such as colon, gastric and endometrial carcinomas with deficient mismatch repair (MMR).
We aimed to perform a comprehensive analysis of the relationship between CIN and MSI mechanisms in sporadic glioblastomas.
<i>Methods:</i> 129 GBMs were examined (109 newly diagnosed and 20 relapses) investigating MSI, immunohistochemical expression of MMR proteins as well as sequencing and promoter methylation of <i>hMLH1</i>.
We characterized the molecular changes frequently correlated with CIN in MSI+ GBMs and compared them with 26 microsatellite-stable tumors.
<i>Results:</i> Low-level MSI was observed in 11 of 129 (8.
5%) cases and was higher in relapses than in primary GBMs (25 vs.
5.
5%, p = 0.
027).
High-level MSI was not found in any case.
A deficient expression of MLH1 and PMS2 without <i>hMLH1</i> inactivation was observed only in one giant cell GBM.
55% of the MSI+ GBMs showed a profile which did not correspond to one of the known CIN pathways.
An inverse association was observed between MSI and mutations of both <i>p53 </i>and <i>PTEN</i>.
<i>Conclusions:</i> Our data suggest that CIN and MSI contribute to the genomic instability in GBMs via independent pathways.
Since MSI was significantly more frequent in relapses, it might play a role in the malignant progression of GBM.
Related Results
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Objective: To determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population...
Investigating the role of the apelinergic system in glioblastoma
Investigating the role of the apelinergic system in glioblastoma
<p>Elucidating the molecular signalling circuitry that underpins the pathogenesis of cancers is critical to understanding and developing effective treatment paradigms for can...
Understanding glioblastoma : cell identity in tissue space
Understanding glioblastoma : cell identity in tissue space
<p dir="ltr"><b>Abstract</b></p><p dir="ltr">Glioblastoma is the most prevalent form of brain cancer among adults. Inherently malignant and aggressive...
Understanding glioblastoma : cell identity in tissue space
Understanding glioblastoma : cell identity in tissue space
<p dir="ltr"><b>Abstract</b></p><p dir="ltr">Glioblastoma is the most prevalent form of brain cancer among adults. Inherently malignant and aggressive...
Glioblastoma Multiforme from Diagnosis to Rehabilitation: a Prospective, Hospital- Based, Case Study of Inpatient Reported Symptoms, Physiotherapy and Functional Improvement
Glioblastoma Multiforme from Diagnosis to Rehabilitation: a Prospective, Hospital- Based, Case Study of Inpatient Reported Symptoms, Physiotherapy and Functional Improvement
A physiotherapist treats patients with Glioblastoma multiforme. Glioblastoma multiforme treatment includes chemotherapy, radiotherapy, and surgery, which are being continuously dev...
BCAT1 regulates glioblastoma cell plasticity and contributes to immunosuppression
BCAT1 regulates glioblastoma cell plasticity and contributes to immunosuppression
Abstract
Glioblastoma is the most common malignant brain tumor in adults. Cellular plasticity and the poorly differentiated features result in a ...
Manajemen anestesi pada pasien Seksio Sesarea Primigravida dengan Glioblastoma Multiforme
Manajemen anestesi pada pasien Seksio Sesarea Primigravida dengan Glioblastoma Multiforme
Tumor otak pada kehamilan jarang terjadi, Glioblastoma multiforme adalah tumor otak primer yang paling agresif dan biasanya membawa prognosis yang buruk. Tumor otak pada kehamilan ...
Abstract 1842: Drug repurposing screen reveals glioblastoma cell line susceptibility to statins
Abstract 1842: Drug repurposing screen reveals glioblastoma cell line susceptibility to statins
Abstract
Background: The standard therapy for glioblastoma patients is tumor resection followed by radiotherapy and temozolomide chemotherapy. Although glioblastoma ...

